Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Updated June 2026 · ClinicalTrials.gov

Istituto Auxologico Italiano

Reviewed by TrialFinderData Editorial Team · Updated

12 clinical trials · 12 recruiting · OTHER

Istituto Auxologico Italiano has 12 clinical trials registered on ClinicalTrials.gov, with 12 actively recruiting participants. The trials listed below cover 18 conditions across the phases listed in the sidebar. Always discuss any specific trial with your physician before contacting a study site.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About Istituto Auxologico Italiano\'s Trial Portfolio

Istituto Auxologico Italiano is a non-industry sponsor (academic medical center, hospital, foundation, or research network). Non-industry sponsors often investigate novel approaches, rare conditions, and behavioral or surgical interventions that commercial sponsors may not prioritize.

12 of Istituto Auxologico Italiano's 12 registered trials are currently recruiting — roughly 100% of the portfolio. A high recruiting share usually points to an active research pipeline with multiple programs at the enrollment stage.

Istituto Auxologico Italiano's research footprint spans Obesity (3 trials), Obesity, Morbid (2), and Thyroid Cancer (1) as the top three conditions. The full condition list, sorted by trial count, is in the sidebar.

is the largest single phase in Istituto Auxologico Italiano's portfolio at 75% of registered trials. The full phase breakdown appears in the sidebar.

Trials by Istituto Auxologico Italiano

RECRUITINGNCT05752604

Impact of Conventional Treatments and Clinical Variables on Thyroid Cancer

DTC has a generally favorable prognosis. The possibility to discriminate between patients with aggressive tumors and those with a more indolent behavior may reduce the need for...

Sponsor: Istituto Auxologico ItalianoEnrolling: 30001 location
Thyroid Cancer
RECRUITINGNCT06343558

Gait and Balance Impairment in Rare and Very Rare Neurological Diseases

Rare and very rare neurological diseases primarily or exclusively affect the nervous system with a prevalence of \< 5 out of 10'000 and 100'000 people, respectively. Besides...

Sponsor: Istituto Auxologico ItalianoEnrolling: 2002 locations
Multiple SclerosisParkinson DiseasePeripheral Neuropathy+3
RECRUITINGNCT06318585

Creation of a Clinical Database for the Study of Phenotypic Variability in Motor Neuron Diseases

Study Description: Characterization of Motor Neuron Disease Phenotypes The goal of this observational study is to understand the clinical presentation of motor neuron disease...

Sponsor: Istituto Auxologico ItalianoEnrolling: 2001 location
Amyotrophic Lateral SclerosisMotor Neuron Disease
RECRUITINGNCT02804074

MASked-unconTrolled hypERtension Management Based on Office BP or on Out-of-office (Ambulatory) BP Measurement

MASTER study is a 4-year prospective, randomized, open-label, blinded-endpoint study (PROBE) comparing 2 management strategies 1) office BP as a guide to treatment, or 2) 24-hour...

Sponsor: Istituto Auxologico ItalianoEnrolling: 12402 locations
Masked Hypertension
RECRUITINGNCT06800807

Metacognitive Beliefs in Adolescents With Eating and Nutrition Disorders

The present study aims to study the presence of metacognitive beliefs in adolescent subjects with eating and nutrition disorders (END) compared with a control group composed of...

Sponsor: Istituto Auxologico ItalianoEnrolling: 721 location
Feeding and Eating Disorders
RECRUITINGNCT06800937

Sphingolipidomic Profile in Anorexia Nervosa

: The objective of this research project will be to determine the sphingolipidomic profile in a group of women (\> 18 years) affected by Anorexia Nervosa (AN), phenotypically...

Sponsor: Istituto Auxologico ItalianoEnrolling: 601 location
Anorexia Nervosa
RECRUITINGNCT05772052

Abnormal Eating and Taste Perception in Subjects With Obesity

The identification of safe and effective strategies for weight loss and long-term maintenance is critical to reduce the alarming prevalence of obesity worldwide and mitigate...

Sponsor: Istituto Auxologico ItalianoEnrolling: 3001 location
Obesity
RECRUITINGNCT05759637

Type 2 Diabetes, Obesity and Cortisol Excess

The present observational cross-sectional study is aimed to assess: the hidden hypercortisolism (HidHyCo) prevalence in a sample of Type 2 diabetes (T2D) patients and the clinical...

Sponsor: Istituto Auxologico ItalianoEnrolling: 32005 locations
Diabetes Mellitus, Type 2ObesityCortisol; Hypersecretion
RECRUITINGNCT05777928

Bariatric Surgery and Modulation of Perceived Satiety

Bariatric surgery is the ideal therapeutic strategy for patients with severe obesity when lifestyle interventions have failed. Unfortunately, weight recovery after surgery affects...

Sponsor: Istituto Auxologico ItalianoEnrolling: 601 location
Obesity, Morbid
RECRUITINGNCT06309563

Metabolic Effects of a Diet Replaced With Essential Amino Acids

The effectiveness of low-protein diets supplemented with essential aminoacid (EAA) formulas in genetic disorders of amino acid (AA) catabolism, such as maple syrup urine disease...

Sponsor: Istituto Auxologico ItalianoEnrolling: 601 location
Obesity MorbidWeight Loss
RECRUITINGNCT06338631

Early Detection of Renal Abnormalities in Metabolically Healthy and Unhealthy Weight Excess"

Overweight and obesity are increasingly prevalent worldwide. Weight excess increases the risk of in developing the metabolic syndrome, which is composed by a set of...

Sponsor: Istituto Auxologico ItalianoEnrolling: 10002 locations
Obesity
RECRUITINGNCT06872242

Italian PheNotypes Obstructive Sleep Apnea Study

Obstructive Sleep Apnea (OSA) is the most common sleep-related breathing disorder, representing a major socioeconomic burden on healthcare systems worldwide. Studies performed in...

Sponsor: Istituto Auxologico ItalianoEnrolling: 500020 locations
Sleep Apnea

How to Approach a Trial Listing

Each trial card above links to a dedicated page with the official ClinicalTrials.gov data plus a plain-English translation of the eligibility criteria. We translate technical terminology (ECOG performance status, hepatic function values, exclusionary lab thresholds) into language that a patient or caregiver can understand, but the original clinical text and the live ClinicalTrials.gov record always govern any actual eligibility decision.

Before contacting a trial site, write down questions for your treating physician using the framework on our 25 Questions guide. Discuss whether the trial fits your treatment plan, what the time commitment looks like, and whether your insurance will cover the standard-of-care portions. Trials are not a substitute for a treatment plan — they are an addition that needs medical guidance to evaluate.

Authoritative Resources

Verify any trial registration directly on ClinicalTrials.gov. For background on the FDA approval pathway that Phase 3 trials feed into, see the FDA drug approval process. For cancer-specific trial guidance, the National Cancer Institute publishes patient-oriented overviews. For global trial registrations beyond the U.S., the WHO ICTRP aggregates registries from around the world.

Frequently Asked Questions

How many clinical trials does Istituto Auxologico Italiano have on ClinicalTrials.gov?

Istituto Auxologico Italiano has 12 clinical trials registered on the federal ClinicalTrials.gov registry, of which 12 are actively recruiting participants right now. These counts come directly from the ClinicalTrials.gov API and are updated as the registry changes.

What conditions does Istituto Auxologico Italiano study?

Istituto Auxologico Italiano's registered trials cover 18 conditions on ClinicalTrials.gov, led by Obesity (3 trials), Obesity, Morbid (2 trials), Thyroid Cancer (1 trial), Multiple Sclerosis (1 trial), Parkinson Disease (1 trial). The complete condition list appears in the sidebar of this page; each condition links to a page listing every recruiting trial in that area, regardless of sponsor.

How do I join a Istituto Auxologico Italiano clinical trial?

Joining a clinical trial is a medical decision that should always involve your treating physician. Each trial page on this site includes the eligibility criteria translated into plain English alongside the official clinical text, plus the contact information that the sponsor has registered with ClinicalTrials.gov. Bring the trial information to your doctor before reaching out — they can review the full inclusion and exclusion criteria against your medical history and help you decide whether to pursue screening.

What does the trial phase mean?

Phase 1 trials test safety and dosing in small groups (often 20–80 healthy volunteers or patients). Phase 2 trials evaluate efficacy and side effects in larger groups (100–300 patients with the target condition). Phase 3 trials confirm efficacy and monitor safety in the largest groups (300–3,000+ patients) and form the basis of an FDA approval submission. Phase 4 studies happen after a treatment is approved, monitoring long-term safety and effectiveness in real-world use. Some trials register without a phase — common for device, behavioral, or observational studies.

Where does this trial data come from?

All trial data is pulled directly from the ClinicalTrials.gov API v2, the official federal trial registry maintained by the National Library of Medicine at NIH. Under FDAAA 801, most U.S. drug and device trials are required to register, making ClinicalTrials.gov the most comprehensive source. Sponsors are responsible for keeping their listings current; trial status can shift between data refreshes.

How This Sponsor Page Is Built

Every count on this page is derived directly from ClinicalTrials.gov API v2 records. Trial counts include all trials currently registered to this sponsor; the recruiting count reflects trials with status "Recruiting" or equivalent. Plain-English eligibility translations on each linked trial page preserve the original clinical text alongside an accessible version. Read the full methodology for the data pipeline and limitations.

Source: ClinicalTrials.gov API v2, maintained by the National Library of Medicine at NIH. Public domain. Cite as: "TrialFinderData. Data: ClinicalTrials.gov."

Medical disclaimer: This page is informational, not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Last updated 2026-06-26 · 12 trials tracked for Istituto Auxologico Italiano.